Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
12.94
-0.33 (-2.49%)
At close: Oct 31, 2025, 4:00 PM EDT
12.95
+0.01 (0.08%)
After-hours: Oct 31, 2025, 6:43 PM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $230.76 million as of October 31, 2025. Its market cap has increased by 3,293.49% in one year.
Market Cap
230.76M
Enterprise Value
124.61M
1-Year Change
3,293.49%
Ranking
Category
Stock Price
$12.94
Market Cap Chart
Since April 13, 2017, Forte Biosciences's market cap has increased from $213.50M to $230.76M, an increase of 8.08%. That is a compound annual growth rate of 0.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 160.90M | 384.64% |
| Dec 31, 2024 | 33.20M | 11.04% |
| Dec 29, 2023 | 29.90M | 42.38% |
| Dec 30, 2022 | 21.00M | -33.54% |
| Dec 31, 2021 | 31.60M | -93.24% |
| Dec 31, 2020 | 467.20M | 3,578.74% |
| Dec 31, 2019 | 12.70M | -92.25% |
| Dec 31, 2018 | 163.80M | -19.31% |
| Dec 29, 2017 | 203.00M | -4.92% |
| Apr 13, 2017 | 213.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |